The BOPA-PRUK research award – launch now open for submissions

The BOPA-PRUK research award

This award provides pharmacy professionals who are new to research with the extra incentive to get their research career started.

Pharmacy Research UK (PRUK) and the British Oncology Pharmacy Association (BOPA) have collaborated together for 7 years to provide this opportunity to oncology and haematology pharmacy colleagues.  Multiple people have already benefited from this generous award.

This year, the award is worth £10,000. This allows us to offer the whole amount to a single person or to break the award down to offer more people smaller amounts of a minimum of £5,000. The funding can be used to partly or fully fund a research project. The funding round closes at 1pm on 26th March 2025.

Any member of the pharmacy team can apply. Projects must be related to the provision of oncology or haematology pharmacy services directly impacting patient care and benefit.

For further information please refer to the PRUK website. We recommend you read through all the material contained within the PRUK website before starting your application.

BOPA offer a mentoring scheme available to pharmacy professionals who wish to seek guidance and support for developing their research skills. If you think you could benefit from this please refer to the BOPA research hub.

Latest News

By BOPA Committee on 22nd January 2025

NIHR INSIGHT Programme South London Research Masters Studentships 2025/26: Call for applications

NIHR INSIGHT Programme South London Research Masters Studentships 2025/26: Call for applications is now open. For more info click here and/or see flyer below.  

Read article
By BOPA research committee on 22nd January 2025

SURVEY: Examining barriers to pharmacy professionals engaging with research

The Incubator for Pharmacy Professionals is an NIHR-supported initiative dedicated to strengthening research capacity within the pharmacy profession. Despite its critical role as a pillar of professional practice, research remains…

Read article
By BOPA on 20th January 2025

Monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

The Immune-Related Adverse Effects that arise from use of checkpoint inhibitors can be difficult to manage, especially when steroids are not enough. Despite there being guidance about how to manage…

Read article
By BOPA Committee on 20th January 2025

UTIC course has been awarded a FIP Seal

UTIC (Understanding targeted therapies and immunotherapies for cancer) course has been awarded a FIP Seal. This is a joint collaboration between BOPA and ISOPP. The FIP Seal for programmes is…

Read article